首页 > 最新文献

JACC. Cardiovascular imaging最新文献

英文 中文
Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial. 他汀类药物对HIV感染者冠状动脉周围脂肪组织密度的影响:来自REPRIEVE试验的见解。
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-24 DOI: 10.1016/j.jcmg.2025.10.012
Borek Foldyna,Ibrahim Hadzic,Thomas Mayrhofer,Júlia Karády,Jana Taron,Márton Kolossváry,Vineet K Raghu,Sara McCallum,Kayla Paradis,Marissa R Diggs,Sarah M Chu,Alex B Lu,Charurut Somboonwit,Jose I Bernardino,Michael P Dubé,Craig A Sponseller,Markella V Zanni,Gerald S Bloomfield,Carlos D Malvestutto,Carl J Fichtenbaum,Judith A Aberg,Judith S Currier,Heather J Ribaudo,Pamela S Douglas,Michael T Lu,Steven K Grinspoon
BACKGROUNDThe effects of statin therapy on pericoronary adipose tissue (PCAT) and its relationship with plaque progression and outcomes in people with HIV (PWH) remain poorly understood.OBJECTIVESThe aim of this study was to evaluate PCAT density changes over time; statin effects on PCAT; and associations among PCAT changes, coronary plaque, and clinical outcomes.METHODSIn the REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) mechanistic computed tomographic (CT) substudy (n = 753, mean age 51 ± 6 years, 17% women), PCAT density was measured from noncontrast CT images at baseline and 2 years, while coronary plaque volumes (total, calcified, and noncalcified) were assessed from contrast-enhanced CT angiograms. Analyses were stratified by coronary artery disease burden (segment involvement score 0, 1-3, or ≥4) and adjusted for technical parameters, atherosclerotic cardiovascular disease risk, body mass index, inflammatory biomarkers, and statin allocation. Associations among PCAT, plaque changes, and events (all-cause mortality, major adverse cardiovascular events [MACE], and MACE or death) were evaluated.RESULTSBaseline PCAT density was -87.7 ± 10.5 HU, increasing by 4.5 HU (95% CI: 3.8-5.2; P < 0.001) over 2 years. Pitavastatin prevented this increase in participants with segment involvement scores ≥4 (-1.7 HU vs +3.8 HU; P = 0.016, pitavastatin vs placebo, respectively). Greater PCAT density was associated with higher noncalcified plaque volume (per +10 HU, +5.0 mm3; P = 0.075) and reduced calcified plaque progression (-3.2 mm3; P = 0.031). Over a median of 6.3 years, 4.2% of patients died. Baseline PCAT density was independently associated with all-cause mortality (HR per +10 HU: 1.95; 95% CI: 1.03-3.69; P = 0.040), but not MACE.CONCLUSIONSPCAT density increases over time in PWH, but pitavastatin mitigates this in those with high coronary artery disease burden. PCAT density is associated with vulnerable plaque morphology and all-cause mortality, supporting its potential as a prognostic imaging biomarker in PWH. (Randomized Trial to Prevent Vascular Events in HIV [REPRIEVE]; NCT02344290).
背景:他汀类药物治疗对HIV (PWH)患者冠状动脉周围脂肪组织(PCAT)的影响及其与斑块进展和结局的关系仍知之甚少。目的:本研究的目的是评估PCAT密度随时间的变化;他汀类药物对PCAT的影响;以及PCAT变化、冠状动脉斑块和临床结果之间的关系。方法在REPRIEVE(预防HIV血管事件的随机试验)机制计算机断层扫描(CT)亚研究(n = 753,平均年龄51±6岁,17%为女性)中,通过基线和2年的非对比CT图像测量PCAT密度,同时通过增强CT血管造影评估冠状动脉斑块体积(总、钙化和非钙化)。根据冠状动脉疾病负担(节段累及评分0、1-3或≥4)对分析进行分层,并根据技术参数、动脉粥样硬化性心血管疾病风险、体重指数、炎症生物标志物和他汀类药物分配进行调整。评估PCAT、斑块变化和事件(全因死亡率、主要不良心血管事件[MACE]以及MACE或死亡)之间的关系。结果基线PCAT密度为-87.7±10.5 HU, 2年内增加4.5 HU (95% CI: 3.8 ~ 5.2; P < 0.001)。匹伐他汀阻止了节段累及评分≥4的参与者的这种增加(-1.7 HU vs +3.8 HU; P = 0.016,匹伐他汀vs安慰剂)。更大的PCAT密度与更高的非钙化斑块体积(每+10 HU, +5.0 mm3, P = 0.075)和更少的钙化斑块进展(-3.2 mm3, P = 0.031)相关。在中位6.3年期间,4.2%的患者死亡。基线PCAT密度与全因死亡率独立相关(HR / +10 HU: 1.95; 95% CI: 1.03-3.69; P = 0.040),但与MACE无关。结论:PWH患者的spcat密度随时间增加,但匹伐他汀可减轻高冠状动脉疾病负担患者的spcat密度。PCAT密度与易损斑块形态和全因死亡率相关,支持其作为PWH预后成像生物标志物的潜力。预防HIV血管事件的随机试验[REPRIEVE]; NCT02344290)。
{"title":"Statin Effects on Pericoronary Adipose Tissue Density in People With HIV: Insights From the REPRIEVE Trial.","authors":"Borek Foldyna,Ibrahim Hadzic,Thomas Mayrhofer,Júlia Karády,Jana Taron,Márton Kolossváry,Vineet K Raghu,Sara McCallum,Kayla Paradis,Marissa R Diggs,Sarah M Chu,Alex B Lu,Charurut Somboonwit,Jose I Bernardino,Michael P Dubé,Craig A Sponseller,Markella V Zanni,Gerald S Bloomfield,Carlos D Malvestutto,Carl J Fichtenbaum,Judith A Aberg,Judith S Currier,Heather J Ribaudo,Pamela S Douglas,Michael T Lu,Steven K Grinspoon","doi":"10.1016/j.jcmg.2025.10.012","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.012","url":null,"abstract":"BACKGROUNDThe effects of statin therapy on pericoronary adipose tissue (PCAT) and its relationship with plaque progression and outcomes in people with HIV (PWH) remain poorly understood.OBJECTIVESThe aim of this study was to evaluate PCAT density changes over time; statin effects on PCAT; and associations among PCAT changes, coronary plaque, and clinical outcomes.METHODSIn the REPRIEVE (Randomized Trial to Prevent Vascular Events in HIV) mechanistic computed tomographic (CT) substudy (n = 753, mean age 51 ± 6 years, 17% women), PCAT density was measured from noncontrast CT images at baseline and 2 years, while coronary plaque volumes (total, calcified, and noncalcified) were assessed from contrast-enhanced CT angiograms. Analyses were stratified by coronary artery disease burden (segment involvement score 0, 1-3, or ≥4) and adjusted for technical parameters, atherosclerotic cardiovascular disease risk, body mass index, inflammatory biomarkers, and statin allocation. Associations among PCAT, plaque changes, and events (all-cause mortality, major adverse cardiovascular events [MACE], and MACE or death) were evaluated.RESULTSBaseline PCAT density was -87.7 ± 10.5 HU, increasing by 4.5 HU (95% CI: 3.8-5.2; P < 0.001) over 2 years. Pitavastatin prevented this increase in participants with segment involvement scores ≥4 (-1.7 HU vs +3.8 HU; P = 0.016, pitavastatin vs placebo, respectively). Greater PCAT density was associated with higher noncalcified plaque volume (per +10 HU, +5.0 mm3; P = 0.075) and reduced calcified plaque progression (-3.2 mm3; P = 0.031). Over a median of 6.3 years, 4.2% of patients died. Baseline PCAT density was independently associated with all-cause mortality (HR per +10 HU: 1.95; 95% CI: 1.03-3.69; P = 0.040), but not MACE.CONCLUSIONSPCAT density increases over time in PWH, but pitavastatin mitigates this in those with high coronary artery disease burden. PCAT density is associated with vulnerable plaque morphology and all-cause mortality, supporting its potential as a prognostic imaging biomarker in PWH. (Randomized Trial to Prevent Vascular Events in HIV [REPRIEVE]; NCT02344290).","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"110 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145645015","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry. 基于人工智能的定量冠状动脉CTA与基于人类阅读器的视觉评估的预后价值:来自CONFIRM2注册表的结果
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-22 DOI: 10.1016/j.jcmg.2025.09.021
Alexander van Rosendael,Rine Nakanishi,Jeroen J Bax,Gianluca Pontone,Saima Mushtaq,Ronny R Buechel,Christoph Gräni,Gudrun Feuchtner,Pietro G Lacaita,Amit R Patel,Cristiane C Singulane,Andrew D Choi,Mouaz Al-Mallah,Daniele Andreini,Ronald P Karlsberg,Geoffrey W Cho,Carlos E Rochitte,Mirvat Alasnag,Ashraf Hamdan,Filippo Cademartiri,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Himanshu Gupta,Martin Hadamitzky,Omar Khalique,Dinesh Kalra,James D Mills,Nick S Nurmohamed,Paul Knaapen,Matthew Budoff,Kashif Shaikh,Enrico Martin,David M German,Maros Ferencik,Andrew C Oehler,Roderick Deaño,Prashant Nagpal,Marly van Assen,Carlo N De Cecco,Vasileios Kamperidis,Borek Foldyna,Jan M Brendel,Victor Y Cheng,Kelley R Branch,Marcio Bittencourt,Sabha Bhatti,Venkateshwar Polsani,George Wesbey,Rhanderson Cardoso,Ron Blankstein,Augustin Delago,Amit Pursnani,Amro Alsaid,Vasvi Singh,Melissa Aquino,Jisuk Park,Ibrahim Danad
BACKGROUNDThe severity and extent of whole heart coronary plaque volume and stenosis can be reliably measured by artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT). Limited data are available on the potential incremental prognostic value compared with currently recommended qualitative coronary computed tomography angiography (CTA) reads and the coronary artery calcium score (CACS).OBJECTIVESThe aim of this study was to evaluate the prognostic value of AI-QCT compared with human coronary CTA reads, including the CAD-RADS (Coronary Artery Disease-Reporting and Data System), CACS, and the modified Duke Index.METHODSCONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) is a multicenter, international, observational cohort study of patients undergoing clinically indicated coronary CTA with follow-up for major adverse cardiac events (MACE). Asymptomatic patients and those with cardiac history were excluded. Coronary artery disease presence, extent, and composition were quantified by AI-QCT across the coronary tree, yielding 24 patient-, vessel-, and plaque-level variables. On the basis of prior analyses, noncalcified plaque burden and diameter stenosis were identified as the strongest predictors and combined for statistical modeling as "AI-QCT." Comparator computed tomography scores included CAD-RADS, CACS, and the modified Duke Index, whereas clinical predictors were summarized in the risk factor-weighted clinical likelihood score. Area under the curve (AUC) and continuous net reclassification index (NRI) were calculated to assess the incremental value. The primary endpoint was MACE (death, myocardial infarction [MI], stroke, heart failure, late revascularization, or hospital stay for unstable angina), and the secondary endpoint was death or MI.RESULTSIn 1,916 patients with all risk scores available, 87 (4.5%) MACE and 27 (1.4%) death/MI events occurred during 3 years of follow-up. There was a stepwise risk increase with higher coronary artery disease classifications with CAD-RADS and CACS. The addition of AI-QCT significantly improved risk stratification for MACE compared with CAD-RADS (AUC: 0.81 vs 0.79; P < 0.001 and NRI: 0.47; P < 0.001), CACS (AUC: 0.79 vs 0.70; P < 0.001 and NRI 0.61; P < 0.001), the modified Duke Index (AUC: 0.81 vs 0.76; P < 0.001 and NRI: 0.52; P < 0.001), and CAD-RADS + CACS model (AUC: 0.81 vs 0.79; P = 0.004 and NRI: 0.54; P < 0.001). AI-QCT also improved discrimination when results were adjusted for the risk factor-weighted clinical likelihood and for the prediction of death/MI. Excluding 195 patients with severe stenosis (≥70%), in a multivariable model of CAD-RADS and AI-QCT, only AI-QCT was significantly associated with MACE and death/MI, and AI-QCT significantly improved risk stratification compared with CAD-RADS for MACE (AUC: 0.77 vs 0.72; P < 0.001 and NRI: 0.54; P < 0.001) and death/MI (AUC:
人工智能引导的定量冠状动脉计算机断层造影(AI-QCT)可以可靠地测量全心冠状动脉斑块体积和狭窄的严重程度和程度。与目前推荐的定性冠状动脉ct血管造影(CTA)读数和冠状动脉钙评分(CACS)相比,关于潜在的增量预后价值的数据有限。目的本研究的目的是评估AI-QCT与人类冠状动脉CTA读数的预后价值,包括CAD-RADS(冠状动脉疾病报告和数据系统)、CACS和改良的Duke指数。方法confirm2(定量冠状动脉CT血管造影评估用于评估临床结果:一项国际多中心注册研究)是一项多中心国际观察性队列研究,研究对象是接受临床指征冠状动脉CTA并随访主要心脏不良事件(MACE)的患者。排除无症状患者和有心脏病史的患者。通过AI-QCT对冠状动脉病变的存在、程度和组成进行量化,得出24个患者、血管和斑块水平变量。在先前分析的基础上,非钙化斑块负担和直径狭窄被确定为最强的预测因子,并将其合并为“AI-QCT”统计模型。比较计算机断层扫描评分包括CAD-RADS、CACS和改进的Duke指数,而临床预测指标则总结为危险因素加权临床似然评分。计算曲线下面积(Area under the curve, AUC)和连续净重分类指数(continuous net reclassification index, NRI)来评估增量值。主要终点为MACE(死亡、心肌梗死[MI]、卒中、心力衰竭、晚期血运重建术或因不稳定心绞痛住院),次要终点为死亡或心肌梗死。结果在获得所有风险评分的1916例患者中,3年随访期间发生了87例(4.5%)MACE和27例(1.4%)死亡/心肌梗死事件。CAD-RADS和CACS的冠状动脉疾病分类越高,风险越高。与CAD-RADS (AUC: 0.81 vs 0.79, P < 0.001, NRI: 0.47, P < 0.001)、CACS (AUC: 0.79 vs 0.70, P < 0.001, NRI 0.61, P < 0.001)、改良杜克指数(AUC: 0.81 vs 0.76, P < 0.001, NRI: 0.52, P < 0.001)和CAD-RADS + CACS模型(AUC: 0.81 vs 0.79, P = 0.004, NRI: 0.54, P < 0.001)相比,AI-QCT的加入显著改善了MACE的风险分层。当对危险因素加权的临床可能性和死亡/心肌梗死的预测结果进行调整时,AI-QCT也提高了识别能力。除195例严重狭窄患者(≥70%)外,在CAD-RADS和AI-QCT的多变量模型中,只有AI-QCT与MACE和死亡/MI显著相关,与CAD-RADS相比,AI-QCT显著改善了MACE (AUC: 0.77 vs 0.72; P < 0.001, NRI: 0.54; P < 0.001)和死亡/MI (AUC: 0.81 vs 0.73; P = 0.011, NRI: 0.69; P = 0.001)的风险分层。结论与CAD-RADS 2.0、CACS和改进的Duke指数相比,sai - qct在预测MACE以及死亡或非致死性心肌梗死的次要终点方面提供了更多的预后信息。
{"title":"Prognostic Value of AI-Based Quantitative Coronary CTA vs Human Reader-Based Visual Assessment: Results From the CONFIRM2 Registry.","authors":"Alexander van Rosendael,Rine Nakanishi,Jeroen J Bax,Gianluca Pontone,Saima Mushtaq,Ronny R Buechel,Christoph Gräni,Gudrun Feuchtner,Pietro G Lacaita,Amit R Patel,Cristiane C Singulane,Andrew D Choi,Mouaz Al-Mallah,Daniele Andreini,Ronald P Karlsberg,Geoffrey W Cho,Carlos E Rochitte,Mirvat Alasnag,Ashraf Hamdan,Filippo Cademartiri,Erica Maffei,Hugo Marques,Pedro de Araújo Gonçalves,Himanshu Gupta,Martin Hadamitzky,Omar Khalique,Dinesh Kalra,James D Mills,Nick S Nurmohamed,Paul Knaapen,Matthew Budoff,Kashif Shaikh,Enrico Martin,David M German,Maros Ferencik,Andrew C Oehler,Roderick Deaño,Prashant Nagpal,Marly van Assen,Carlo N De Cecco,Vasileios Kamperidis,Borek Foldyna,Jan M Brendel,Victor Y Cheng,Kelley R Branch,Marcio Bittencourt,Sabha Bhatti,Venkateshwar Polsani,George Wesbey,Rhanderson Cardoso,Ron Blankstein,Augustin Delago,Amit Pursnani,Amro Alsaid,Vasvi Singh,Melissa Aquino,Jisuk Park,Ibrahim Danad","doi":"10.1016/j.jcmg.2025.09.021","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.09.021","url":null,"abstract":"BACKGROUNDThe severity and extent of whole heart coronary plaque volume and stenosis can be reliably measured by artificial intelligence-guided quantitative coronary computed tomography angiography (AI-QCT). Limited data are available on the potential incremental prognostic value compared with currently recommended qualitative coronary computed tomography angiography (CTA) reads and the coronary artery calcium score (CACS).OBJECTIVESThe aim of this study was to evaluate the prognostic value of AI-QCT compared with human coronary CTA reads, including the CAD-RADS (Coronary Artery Disease-Reporting and Data System), CACS, and the modified Duke Index.METHODSCONFIRM2 (Quantitative COroNary CT Angiography Evaluation For Evaluation of Clinical Outcomes: An InteRnational, Multicenter Registry) is a multicenter, international, observational cohort study of patients undergoing clinically indicated coronary CTA with follow-up for major adverse cardiac events (MACE). Asymptomatic patients and those with cardiac history were excluded. Coronary artery disease presence, extent, and composition were quantified by AI-QCT across the coronary tree, yielding 24 patient-, vessel-, and plaque-level variables. On the basis of prior analyses, noncalcified plaque burden and diameter stenosis were identified as the strongest predictors and combined for statistical modeling as \"AI-QCT.\" Comparator computed tomography scores included CAD-RADS, CACS, and the modified Duke Index, whereas clinical predictors were summarized in the risk factor-weighted clinical likelihood score. Area under the curve (AUC) and continuous net reclassification index (NRI) were calculated to assess the incremental value. The primary endpoint was MACE (death, myocardial infarction [MI], stroke, heart failure, late revascularization, or hospital stay for unstable angina), and the secondary endpoint was death or MI.RESULTSIn 1,916 patients with all risk scores available, 87 (4.5%) MACE and 27 (1.4%) death/MI events occurred during 3 years of follow-up. There was a stepwise risk increase with higher coronary artery disease classifications with CAD-RADS and CACS. The addition of AI-QCT significantly improved risk stratification for MACE compared with CAD-RADS (AUC: 0.81 vs 0.79; P &lt; 0.001 and NRI: 0.47; P &lt; 0.001), CACS (AUC: 0.79 vs 0.70; P &lt; 0.001 and NRI 0.61; P &lt; 0.001), the modified Duke Index (AUC: 0.81 vs 0.76; P &lt; 0.001 and NRI: 0.52; P &lt; 0.001), and CAD-RADS + CACS model (AUC: 0.81 vs 0.79; P = 0.004 and NRI: 0.54; P &lt; 0.001). AI-QCT also improved discrimination when results were adjusted for the risk factor-weighted clinical likelihood and for the prediction of death/MI. Excluding 195 patients with severe stenosis (≥70%), in a multivariable model of CAD-RADS and AI-QCT, only AI-QCT was significantly associated with MACE and death/MI, and AI-QCT significantly improved risk stratification compared with CAD-RADS for MACE (AUC: 0.77 vs 0.72; P &lt; 0.001 and NRI: 0.54; P &lt; 0.001) and death/MI (AUC: ","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"14 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644904","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prediction of Left Ventricular Reverse Remodeling Using 18F-FAPI-74 PET/CT in Nonischemic Dilated Cardiomyopathy. 18F-FAPI-74 PET/CT对非缺血性扩张型心肌病左心室反向重构的预测
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-21 DOI: 10.1016/j.jcmg.2025.10.002
Wenyan Liu,Qiuyan Wu,Xue Yu,Jialin Song,Yuchun Zhao,Feifei Pan,Jiangnan Xiang,Xiaomeng Ma,Xiaoqin Luo,Qi Zhang,Huanzhen Chen,Chunrong Jin,Zhifang Wu,Li Li,Sijin Li
{"title":"Prediction of Left Ventricular Reverse Remodeling Using 18F-FAPI-74 PET/CT in Nonischemic Dilated Cardiomyopathy.","authors":"Wenyan Liu,Qiuyan Wu,Xue Yu,Jialin Song,Yuchun Zhao,Feifei Pan,Jiangnan Xiang,Xiaomeng Ma,Xiaoqin Luo,Qi Zhang,Huanzhen Chen,Chunrong Jin,Zhifang Wu,Li Li,Sijin Li","doi":"10.1016/j.jcmg.2025.10.002","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.002","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"198200 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145644937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Distance and Likelihood of Cardiovascular Imaging Receipt Among Medicare Beneficiaries: Cardiovascular Imaging Deserts Among Medicare Beneficiaries. 医疗保险受益人心血管成像接收的距离和可能性:医疗保险受益人的心血管成像沙漠。
IF 15.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-21 DOI: 10.1016/j.jcmg.2025.10.018
Nicholas Spetko, Yang Song, Hibiki Orui, Constance Angell-James, Madeline Cassidy, Kan Liu, Ron Blankstein, Sanjay Divakaran, Rishi K Wadhera, Jordan B Strom

Background: It is unclear whether geographic distance to a cardiovascular imaging center (CVIC) is associated with receipt of cardiovascular imaging (CVI).

Objectives: This study sought to assess temporal trends in distance to a CVIC and examine the relationship of distance to a CVIC and receipt of CVI overall and by modality.

Methods: Among 64,260,530 older U.S. Medicare fee-for-service and Medicare Advantage beneficiaries from 2018 to 2021, the study measured individual distances to the nearest CVIC. Poisson regression was used to evaluate the likelihood of receipt of CVI as a function of distance, overall and by modality.

Results: Of those beneficiaries included (age: 73.0 ± 8 years; 54.6% female; 80.1% White), 17.5% underwent CVI. The number of CVICs increased (0.02% per year), but median distances to CVICs remained stable (3.3-3.4 miles). Compared with beneficiaries living 10 to 16 miles from a CVIC, distance >16 miles from a CVIC was associated with lower likelihood of receipt (rate ratio: 0.957 [95% CI: 0.956-0.959]; P < 0.001). The lowest likelihood of receipt was within 10 miles of services (rate ratio: 0.923 [95% CI: 0.921-0.924]; P < 0.001). Distances to cardiac computed tomography (CCT), cardiac magnetic resonance (CMR), and positron emission tomography (PET) services were longer than distances to echocardiography and single-photon emission computed tomography (SPECT) services: (median distance: CCT: 8.1 miles [Q1-Q3: 3.7-21.3 miles]; CMR: 17.4 miles [Q1-Q3: 7.3-43.3 miles]; and PET: 88.9 miles [Q1-Q3: 26.2-194.6 miles] vs echocardiography: 3.4 miles [Q1-Q3: 0.4-7.0 miles]; and SPECT: 3.8 miles [Q1-Q3: 1.3-7.9 miles]).

Conclusions: From 2018 to 2021, the number of CVICs increased, although distances to CVICs remained stable. The lowest likelihood receipt of imaging overall was among those patients living within 10 miles of a CVIC, a finding suggesting that proximity is insufficient for access. CCT, CMR, and PET services were concentrated in large metropolitan academic centers.

背景:目前尚不清楚到心血管成像中心(CVIC)的地理距离是否与心血管成像(CVI)的接收有关。目的:本研究旨在评估到CVIC的距离的时间趋势,并检查到CVIC的距离与总体上和按模式接收CVI的关系。方法:在2018年至2021年的64,260,530名老年美国医疗保险按服务收费和医疗保险优惠受益人中,研究测量了个人到最近的CVIC的距离。使用泊松回归来评估接收CVI的可能性作为距离,总体和模态的函数。结果:在纳入的受益人中(年龄:73.0±8岁;54.6%女性;80.1%白人),17.5%接受了CVI。cvc的数量增加(每年0.02%),但到cvc的中位数距离保持稳定(3.3-3.4英里)。与居住在距离CVIC 10至16英里的受益人相比,距离CVIC 16英里与较低的接受可能性相关(比率比:0.957 [95% CI: 0.956-0.959]; P < 0.001)。最低的接受可能性是在10英里的服务范围内(比率比:0.923 [95% CI: 0.921-0.924]; P < 0.001)。到心脏计算机断层扫描(CCT)、心脏磁共振(CMR)和正电子发射断层扫描(PET)服务的距离比到超声心动图和单光子发射计算机断层扫描(SPECT)服务的距离要长:(中间距离:CCT: 8.1英里[Q1-Q3: 3.7-21.3英里];CMR: 17.4英里[Q1-Q3: 7.3-43.3英里];PET: 88.9英里[Q1-Q3: 26.2-194.6英里]vs超声心动图:3.4英里[Q1-Q3: 0.4-7.0英里];SPECT: 3.8英里[Q1-Q3: 1.3-7.9英里])。结论:从2018年到2021年,cvc的数量增加,尽管到cvc的距离保持稳定。总体而言,接受影像学检查的可能性最低的是那些居住在距离中心10英里以内的患者,这一发现表明,距离不够近。CCT、CMR和PET服务主要集中在大城市学术中心。
{"title":"Distance and Likelihood of Cardiovascular Imaging Receipt Among Medicare Beneficiaries: Cardiovascular Imaging Deserts Among Medicare Beneficiaries.","authors":"Nicholas Spetko, Yang Song, Hibiki Orui, Constance Angell-James, Madeline Cassidy, Kan Liu, Ron Blankstein, Sanjay Divakaran, Rishi K Wadhera, Jordan B Strom","doi":"10.1016/j.jcmg.2025.10.018","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.018","url":null,"abstract":"<p><strong>Background: </strong>It is unclear whether geographic distance to a cardiovascular imaging center (CVIC) is associated with receipt of cardiovascular imaging (CVI).</p><p><strong>Objectives: </strong>This study sought to assess temporal trends in distance to a CVIC and examine the relationship of distance to a CVIC and receipt of CVI overall and by modality.</p><p><strong>Methods: </strong>Among 64,260,530 older U.S. Medicare fee-for-service and Medicare Advantage beneficiaries from 2018 to 2021, the study measured individual distances to the nearest CVIC. Poisson regression was used to evaluate the likelihood of receipt of CVI as a function of distance, overall and by modality.</p><p><strong>Results: </strong>Of those beneficiaries included (age: 73.0 ± 8 years; 54.6% female; 80.1% White), 17.5% underwent CVI. The number of CVICs increased (0.02% per year), but median distances to CVICs remained stable (3.3-3.4 miles). Compared with beneficiaries living 10 to 16 miles from a CVIC, distance >16 miles from a CVIC was associated with lower likelihood of receipt (rate ratio: 0.957 [95% CI: 0.956-0.959]; P < 0.001). The lowest likelihood of receipt was within 10 miles of services (rate ratio: 0.923 [95% CI: 0.921-0.924]; P < 0.001). Distances to cardiac computed tomography (CCT), cardiac magnetic resonance (CMR), and positron emission tomography (PET) services were longer than distances to echocardiography and single-photon emission computed tomography (SPECT) services: (median distance: CCT: 8.1 miles [Q1-Q3: 3.7-21.3 miles]; CMR: 17.4 miles [Q1-Q3: 7.3-43.3 miles]; and PET: 88.9 miles [Q1-Q3: 26.2-194.6 miles] vs echocardiography: 3.4 miles [Q1-Q3: 0.4-7.0 miles]; and SPECT: 3.8 miles [Q1-Q3: 1.3-7.9 miles]).</p><p><strong>Conclusions: </strong>From 2018 to 2021, the number of CVICs increased, although distances to CVICs remained stable. The lowest likelihood receipt of imaging overall was among those patients living within 10 miles of a CVIC, a finding suggesting that proximity is insufficient for access. CCT, CMR, and PET services were concentrated in large metropolitan academic centers.</p>","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":" ","pages":""},"PeriodicalIF":15.2,"publicationDate":"2025-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145668520","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodality Imaging Vignettes of Left Ventricular Assist Device Complications 左心室辅助装置并发症的多模态影像小片段
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-20 DOI: 10.1016/j.jcmg.2025.10.017
Nicola Ciocca, David Reineke, Lukas Hunziker, Beate Hugi-Mayr, Michele Martinelli, Lukas Capek, Moritz Hundertmark, Monika Fürholz, Bruno Schnegg, Christoph Gräni
{"title":"Multimodality Imaging Vignettes of Left Ventricular Assist Device Complications","authors":"Nicola Ciocca, David Reineke, Lukas Hunziker, Beate Hugi-Mayr, Michele Martinelli, Lukas Capek, Moritz Hundertmark, Monika Fürholz, Bruno Schnegg, Christoph Gräni","doi":"10.1016/j.jcmg.2025.10.017","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.017","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"37 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145553910","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of MRI- and CTA-Based Plaque-RADS to Predict Stroke and TIA in Symptomatic Carotid Disease 基于MRI和cta的斑块rads预测症状性颈动脉疾病卒中和TIA的比较
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-20 DOI: 10.1016/j.jcmg.2025.10.009
Juul Bierens, Alida A. Postma, Kimberly Frehe, Bart A.J.M. Wagemans, Daniel Bos, Pim A. de Jong, Paul J. Nederkoorn, Werner H. Mess, Anna Kopczak, Andreas Schindler, Tobias Saam, Luca Saba, Luc J.M. Smits, Robert J. van Oostenbrugge, M. Eline Kooi
{"title":"Comparison of MRI- and CTA-Based Plaque-RADS to Predict Stroke and TIA in Symptomatic Carotid Disease","authors":"Juul Bierens, Alida A. Postma, Kimberly Frehe, Bart A.J.M. Wagemans, Daniel Bos, Pim A. de Jong, Paul J. Nederkoorn, Werner H. Mess, Anna Kopczak, Andreas Schindler, Tobias Saam, Luca Saba, Luc J.M. Smits, Robert J. van Oostenbrugge, M. Eline Kooi","doi":"10.1016/j.jcmg.2025.10.009","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.009","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"134 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145553621","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
AI-Based Coronary Plaque Quantification: Better by an Inch or a Mile? 基于人工智能的冠状动脉斑块定量:一英寸还是一英里?
IF 15.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-19 DOI: 10.1016/j.jcmg.2025.10.014
Khurram Nasir, Todd C Villines
{"title":"AI-Based Coronary Plaque Quantification: Better by an Inch or a Mile?","authors":"Khurram Nasir, Todd C Villines","doi":"10.1016/j.jcmg.2025.10.014","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.014","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":" ","pages":""},"PeriodicalIF":15.2,"publicationDate":"2025-11-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145648616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Echocardiographic Outcomes After Transcatheter Edge-to-Edge Repair in Patients With Isolated Tricuspid Regurgitation: The Tri.Fr Trial. 孤立性三尖瓣反流患者经导管边缘对边缘修复后的超声心动图结果:Fr审判。
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-18 DOI: 10.1016/j.jcmg.2025.09.010
Augustin Coisne,Guillaume L'Official,Julien Dreyfus,Julien Ternacle,Guillaume Leurent,Pierre-Yves Le Roux,Anne Ganivet,Catherine Sportouch-Dukhan,Yoan Lavie-Badie,Patrice Guerin,Frédéric Rouleau,Christelle Diakov,Jan Van Der Heyden,Jean-François Obadia,Mohammed Nejjari,Nicole Karam,Anne Bernard,Antoinette Neylon,Romain Pierrard,Didier Tchetche,Said Ghostine,Sabina Istratoaie,Erwan Donal
BACKGROUNDThe relationships among tricuspid regurgitation (TR) reduction after tricuspid transcatheter edge-to-edge repair (T-TEER), changes in right-sided heart function, and outcomes are poorly explored.OBJECTIVESThis study aims to explore the relationship between functional remodeling and subsequent outcomes and the associations among T-TEER, residual TR, and outcomes.METHODSChanges in echocardiographic parameters from baseline to 1 year, overall and according to TR reduction were evaluated by a centralized echocardiographic core laboratory in patients included in the Tri.Fr (Evaluation of Tricuspid Valve Percutaneous Repair System in the Treatment of Severe Secondary Tricuspid Disorders) trial.RESULTSA total of 300 patients (aged 78 ± 5 years; 53.7% women) were enrolled; 152 patients were allocated to the T-TEER + guideline-directed medical therapy (GDMT) group, and 148 were allocated to the GDMT group. Patients in the T-TEER + GDMT group demonstrated a significant decrease in most of parameters of right ventricular (RV) function, whereas patients in the GDMT group exhibited no significant changes in RV metrics at 1 year. The clinical composite score improved progressively with each successive grade of TR reduction. The positive effect of T-TEER on the composite clinical score was observed irrespective of baseline right atrial volume but only in patients with normal RV-pulmonary artery coupling (defined by a tricuspid annular plane systolic excursion-to-systolic pulmonary artery pressure ratio ≥0.40). At 1 year, patients with an improved clinical composite score had a lower right atrial volume index compared with patients whose clinical score remained unchanged or worsened (median 112 mL/m2 [Q1-Q3: 78.0-146 mL/m2] vs median 141 mL/m2 [Q1-Q3: 107-173 mL/m2]; P = 0.004).CONCLUSIONSAlthough T-TEER can decrease TR severity, its impact on conventional RV function parameters and RV-pulmonary artery coupling remains limited. RV functional recovery has a smaller influence on clinical outcomes at 1 year compared with achieving optimal reduction in TR severity. (Evaluation of Tricuspid Valve Percutaneous Repair System in the Treatment of Severe Secondary Tricuspid Disorders [Tri.Fr]; NCT04646811).
背景三尖瓣经导管边缘到边缘修复(T-TEER)后三尖瓣返流(TR)减少、右侧心功能改变和预后之间的关系尚不清楚。目的本研究旨在探讨功能重塑与预后的关系,以及T-TEER、剩余TR与预后的关系。方法通过中央超声心动图核心实验室对纳入Tri的患者从基线到1年的超声心动图参数的变化进行总体和根据TR降低进行评估。Fr(三尖瓣经皮修复系统在治疗严重继发性三尖瓣疾病中的评价)试验。结果共纳入300例患者(年龄78±5岁,女性53.7%);152例患者被分配到T-TEER +指南导向药物治疗(GDMT)组,148例患者被分配到GDMT组。T-TEER + GDMT组患者右心室(RV)功能的大多数参数显着下降,而GDMT组患者在1年后右心室指标没有显着变化。临床综合评分随着TR的逐级降低而逐渐提高。T-TEER对综合临床评分的积极影响与基线右心房容积无关,但仅在心室-肺动脉偶联正常的患者中(以三尖瓣环平面收缩期偏移与收缩期肺动脉压比≥0.40定义)。1年时,临床综合评分改善的患者右房容积指数低于临床评分不变或恶化的患者(中位112 mL/m2 [Q1-Q3: 77.0 -146 mL/m2] vs中位141 mL/m2 [Q1-Q3: 107-173 mL/m2]; P = 0.004)。结论T-TEER虽能降低TR严重程度,但对常规右心室功能参数及右心室-肺动脉耦合的影响有限。与实现TR严重程度的最佳降低相比,RV功能恢复对1年临床结果的影响较小。三尖瓣经皮修复系统在重度继发性三尖瓣病变治疗中的应用[j]; contemporary medicine; 2011 - 12
{"title":"Echocardiographic Outcomes After Transcatheter Edge-to-Edge Repair in Patients With Isolated Tricuspid Regurgitation: The Tri.Fr Trial.","authors":"Augustin Coisne,Guillaume L'Official,Julien Dreyfus,Julien Ternacle,Guillaume Leurent,Pierre-Yves Le Roux,Anne Ganivet,Catherine Sportouch-Dukhan,Yoan Lavie-Badie,Patrice Guerin,Frédéric Rouleau,Christelle Diakov,Jan Van Der Heyden,Jean-François Obadia,Mohammed Nejjari,Nicole Karam,Anne Bernard,Antoinette Neylon,Romain Pierrard,Didier Tchetche,Said Ghostine,Sabina Istratoaie,Erwan Donal","doi":"10.1016/j.jcmg.2025.09.010","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.09.010","url":null,"abstract":"BACKGROUNDThe relationships among tricuspid regurgitation (TR) reduction after tricuspid transcatheter edge-to-edge repair (T-TEER), changes in right-sided heart function, and outcomes are poorly explored.OBJECTIVESThis study aims to explore the relationship between functional remodeling and subsequent outcomes and the associations among T-TEER, residual TR, and outcomes.METHODSChanges in echocardiographic parameters from baseline to 1 year, overall and according to TR reduction were evaluated by a centralized echocardiographic core laboratory in patients included in the Tri.Fr (Evaluation of Tricuspid Valve Percutaneous Repair System in the Treatment of Severe Secondary Tricuspid Disorders) trial.RESULTSA total of 300 patients (aged 78 ± 5 years; 53.7% women) were enrolled; 152 patients were allocated to the T-TEER + guideline-directed medical therapy (GDMT) group, and 148 were allocated to the GDMT group. Patients in the T-TEER + GDMT group demonstrated a significant decrease in most of parameters of right ventricular (RV) function, whereas patients in the GDMT group exhibited no significant changes in RV metrics at 1 year. The clinical composite score improved progressively with each successive grade of TR reduction. The positive effect of T-TEER on the composite clinical score was observed irrespective of baseline right atrial volume but only in patients with normal RV-pulmonary artery coupling (defined by a tricuspid annular plane systolic excursion-to-systolic pulmonary artery pressure ratio ≥0.40). At 1 year, patients with an improved clinical composite score had a lower right atrial volume index compared with patients whose clinical score remained unchanged or worsened (median 112 mL/m2 [Q1-Q3: 78.0-146 mL/m2] vs median 141 mL/m2 [Q1-Q3: 107-173 mL/m2]; P = 0.004).CONCLUSIONSAlthough T-TEER can decrease TR severity, its impact on conventional RV function parameters and RV-pulmonary artery coupling remains limited. RV functional recovery has a smaller influence on clinical outcomes at 1 year compared with achieving optimal reduction in TR severity. (Evaluation of Tricuspid Valve Percutaneous Repair System in the Treatment of Severe Secondary Tricuspid Disorders [Tri.Fr]; NCT04646811).","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"154 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145545134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tricuspid Valve Morphology: Impact on the Standard Echocardiographic Nomenclature. 三尖瓣形态:对标准超声心动图命名法的影响。
IF 14 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-13 DOI: 10.1016/j.jcmg.2025.10.011
Monica De Gaspari,Julien Dreyfus,Francesco Maisano,Stefania Rizzo,Rebecca T Hahn,Cristina Basso
{"title":"Tricuspid Valve Morphology: Impact on the Standard Echocardiographic Nomenclature.","authors":"Monica De Gaspari,Julien Dreyfus,Francesco Maisano,Stefania Rizzo,Rebecca T Hahn,Cristina Basso","doi":"10.1016/j.jcmg.2025.10.011","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.011","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":"19 1","pages":""},"PeriodicalIF":14.0,"publicationDate":"2025-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145545084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Prognostic Value of LGE in LV Dilatation With Preserved LVEF and Dilated Cardiomyopathy. LGE在左室扩张保留左室血流因子和扩张型心肌病预后的比较价值。
IF 15.2 1区 医学 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2025-11-05 DOI: 10.1016/j.jcmg.2025.10.008
Trecy Gonçalves, Théo Pezel, Suzanne Duhamel, Francesca Sanguineti, Philippe Garot, Alexandre Unger, Jean Guillaume Dillinger, Valérie Bousson, Solenn Toupin, Jérôme Garot
{"title":"Comparative Prognostic Value of LGE in LV Dilatation With Preserved LVEF and Dilated Cardiomyopathy.","authors":"Trecy Gonçalves, Théo Pezel, Suzanne Duhamel, Francesca Sanguineti, Philippe Garot, Alexandre Unger, Jean Guillaume Dillinger, Valérie Bousson, Solenn Toupin, Jérôme Garot","doi":"10.1016/j.jcmg.2025.10.008","DOIUrl":"https://doi.org/10.1016/j.jcmg.2025.10.008","url":null,"abstract":"","PeriodicalId":14767,"journal":{"name":"JACC. Cardiovascular imaging","volume":" ","pages":""},"PeriodicalIF":15.2,"publicationDate":"2025-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145458778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
JACC. Cardiovascular imaging
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1